Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8439 |
Intermediate Similarity |
NPD4079 |
Approved |
0.8439 |
Intermediate Similarity |
NPD4076 |
Approved |
0.8418 |
Intermediate Similarity |
NPD8431 |
Approved |
0.8382 |
Intermediate Similarity |
NPD3506 |
Approved |
0.8382 |
Intermediate Similarity |
NPD3505 |
Approved |
0.8304 |
Intermediate Similarity |
NPD4184 |
Clinical (unspecified phase) |
0.8286 |
Intermediate Similarity |
NPD6595 |
Phase 3 |
0.8191 |
Intermediate Similarity |
NPD7958 |
Clinical (unspecified phase) |
0.8191 |
Intermediate Similarity |
NPD7957 |
Phase 1 |
0.8171 |
Intermediate Similarity |
NPD6203 |
Clinical (unspecified phase) |
0.8161 |
Intermediate Similarity |
NPD5065 |
Approved |
0.814 |
Intermediate Similarity |
NPD5069 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD5744 |
Clinical (unspecified phase) |
0.8114 |
Intermediate Similarity |
NPD6375 |
Clinical (unspecified phase) |
0.8105 |
Intermediate Similarity |
NPD7947 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD6610 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD6026 |
Approved |
0.807 |
Intermediate Similarity |
NPD3323 |
Discontinued |
0.8068 |
Intermediate Similarity |
NPD2144 |
Approved |
0.8034 |
Intermediate Similarity |
NPD3038 |
Discontinued |
0.7989 |
Intermediate Similarity |
NPD5728 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD1722 |
Approved |
0.7967 |
Intermediate Similarity |
NPD8110 |
Clinical (unspecified phase) |
0.7966 |
Intermediate Similarity |
NPD4181 |
Approved |
0.7964 |
Intermediate Similarity |
NPD2172 |
Phase 1 |
0.7963 |
Intermediate Similarity |
NPD786 |
Approved |
0.7931 |
Intermediate Similarity |
NPD4639 |
Approved |
0.7931 |
Intermediate Similarity |
NPD4638 |
Approved |
0.7931 |
Intermediate Similarity |
NPD4640 |
Approved |
0.7904 |
Intermediate Similarity |
NPD4374 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD3100 |
Discontinued |
0.7888 |
Intermediate Similarity |
NPD198 |
Clinical (unspecified phase) |
0.7861 |
Intermediate Similarity |
NPD7948 |
Phase 1 |
0.7857 |
Intermediate Similarity |
NPD8112 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD4128 |
Approved |
0.7809 |
Intermediate Similarity |
NPD749 |
Clinical (unspecified phase) |
0.7809 |
Intermediate Similarity |
NPD4075 |
Phase 2 |
0.7796 |
Intermediate Similarity |
NPD5575 |
Clinical (unspecified phase) |
0.7753 |
Intermediate Similarity |
NPD482 |
Approved |
0.7751 |
Intermediate Similarity |
NPD4463 |
Approved |
0.7751 |
Intermediate Similarity |
NPD4462 |
Approved |
0.774 |
Intermediate Similarity |
NPD3610 |
Approved |
0.774 |
Intermediate Similarity |
NPD3609 |
Approved |
0.7737 |
Intermediate Similarity |
NPD4601 |
Approved |
0.7737 |
Intermediate Similarity |
NPD4600 |
Approved |
0.7727 |
Intermediate Similarity |
NPD5021 |
Discontinued |
0.7717 |
Intermediate Similarity |
NPD3486 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD2092 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD2125 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD2094 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD2095 |
Phase 2 |
0.7688 |
Intermediate Similarity |
NPD6630 |
Clinical (unspecified phase) |
0.7684 |
Intermediate Similarity |
NPD1325 |
Approved |
0.7684 |
Intermediate Similarity |
NPD1326 |
Approved |
0.7667 |
Intermediate Similarity |
NPD8123 |
Approved |
0.7667 |
Intermediate Similarity |
NPD8122 |
Approved |
0.765 |
Intermediate Similarity |
NPD2091 |
Phase 2 |
0.765 |
Intermediate Similarity |
NPD2096 |
Phase 2 |
0.7633 |
Intermediate Similarity |
NPD4703 |
Approved |
0.7633 |
Intermediate Similarity |
NPD4702 |
Approved |
0.7627 |
Intermediate Similarity |
NPD4779 |
Clinical (unspecified phase) |
0.7624 |
Intermediate Similarity |
NPD8386 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD3961 |
Discontinued |
0.7617 |
Intermediate Similarity |
NPD8072 |
Approved |
0.7598 |
Intermediate Similarity |
NPD4112 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD8464 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD7944 |
Discontinued |
0.7565 |
Intermediate Similarity |
NPD5721 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD5254 |
Discontinued |
0.7558 |
Intermediate Similarity |
NPD2837 |
Discontinued |
0.7557 |
Intermediate Similarity |
NPD6635 |
Approved |
0.7542 |
Intermediate Similarity |
NPD5934 |
Clinical (unspecified phase) |
0.754 |
Intermediate Similarity |
NPD6281 |
Approved |
0.7528 |
Intermediate Similarity |
NPD2640 |
Approved |
0.7528 |
Intermediate Similarity |
NPD2641 |
Approved |
0.7513 |
Intermediate Similarity |
NPD1038 |
Approved |
0.75 |
Intermediate Similarity |
NPD8493 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD750 |
Phase 2 |
0.7487 |
Intermediate Similarity |
NPD7234 |
Approved |
0.7487 |
Intermediate Similarity |
NPD8272 |
Phase 2 |
0.7487 |
Intermediate Similarity |
NPD6664 |
Approved |
0.7487 |
Intermediate Similarity |
NPD7233 |
Approved |
0.7485 |
Intermediate Similarity |
NPD3943 |
Clinical (unspecified phase) |
0.7475 |
Intermediate Similarity |
NPD7998 |
Clinical (unspecified phase) |
0.7474 |
Intermediate Similarity |
NPD8073 |
Approved |
0.7474 |
Intermediate Similarity |
NPD7618 |
Phase 3 |
0.7474 |
Intermediate Similarity |
NPD7619 |
Phase 3 |
0.746 |
Intermediate Similarity |
NPD6619 |
Phase 3 |
0.746 |
Intermediate Similarity |
NPD3404 |
Approved |
0.7459 |
Intermediate Similarity |
NPD3607 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD2928 |
Phase 2 |
0.745 |
Intermediate Similarity |
NPD8094 |
Discontinued |
0.7443 |
Intermediate Similarity |
NPD1404 |
Approved |
0.7443 |
Intermediate Similarity |
NPD1403 |
Approved |
0.7421 |
Intermediate Similarity |
NPD1304 |
Clinical (unspecified phase) |
0.7418 |
Intermediate Similarity |
NPD2380 |
Approved |
0.7418 |
Intermediate Similarity |
NPD2381 |
Approved |
0.7418 |
Intermediate Similarity |
NPD2382 |
Approved |
0.7409 |
Intermediate Similarity |
NPD6661 |
Clinical (unspecified phase) |
0.7409 |
Intermediate Similarity |
NPD7621 |
Clinical (unspecified phase) |
0.7401 |
Intermediate Similarity |
NPD972 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD8093 |
Discontinued |
0.7398 |
Intermediate Similarity |
NPD5426 |
Phase 3 |
0.7396 |
Intermediate Similarity |
NPD3717 |
Discontinued |
0.7387 |
Intermediate Similarity |
NPD7809 |
Clinical (unspecified phase) |
0.7374 |
Intermediate Similarity |
NPD2639 |
Approved |
0.7374 |
Intermediate Similarity |
NPD2642 |
Approved |
0.7371 |
Intermediate Similarity |
NPD2580 |
Discontinued |
0.736 |
Intermediate Similarity |
NPD4862 |
Clinical (unspecified phase) |
0.735 |
Intermediate Similarity |
NPD5067 |
Phase 2 |
0.735 |
Intermediate Similarity |
NPD5066 |
Phase 2 |
0.735 |
Intermediate Similarity |
NPD7470 |
Discontinued |
0.734 |
Intermediate Similarity |
NPD5590 |
Clinical (unspecified phase) |
0.734 |
Intermediate Similarity |
NPD3002 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD2185 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD4511 |
Phase 1 |
0.7323 |
Intermediate Similarity |
NPD6838 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD3825 |
Phase 3 |
0.731 |
Intermediate Similarity |
NPD5901 |
Discontinued |
0.7304 |
Intermediate Similarity |
NPD8405 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD1853 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD5315 |
Discontinued |
0.73 |
Intermediate Similarity |
NPD7825 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD7187 |
Phase 2 |
0.7294 |
Intermediate Similarity |
NPD4637 |
Clinical (unspecified phase) |
0.7287 |
Intermediate Similarity |
NPD4426 |
Clinical (unspecified phase) |
0.7287 |
Intermediate Similarity |
NPD6217 |
Discontinued |
0.7282 |
Intermediate Similarity |
NPD8248 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD6148 |
Clinical (unspecified phase) |
0.7264 |
Intermediate Similarity |
NPD8013 |
Clinical (unspecified phase) |
0.7243 |
Intermediate Similarity |
NPD6555 |
Clinical (unspecified phase) |
0.724 |
Intermediate Similarity |
NPD802 |
Phase 2 |
0.7236 |
Intermediate Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD1592 |
Phase 3 |
0.7234 |
Intermediate Similarity |
NPD7424 |
Clinical (unspecified phase) |
0.7232 |
Intermediate Similarity |
NPD5541 |
Clinical (unspecified phase) |
0.7228 |
Intermediate Similarity |
NPD7594 |
Clinical (unspecified phase) |
0.7228 |
Intermediate Similarity |
NPD5100 |
Phase 3 |
0.7228 |
Intermediate Similarity |
NPD8458 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD5912 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD5913 |
Phase 3 |
0.7225 |
Intermediate Similarity |
NPD4547 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD5522 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD6975 |
Discontinued |
0.7206 |
Intermediate Similarity |
NPD5612 |
Discontinued |
0.7204 |
Intermediate Similarity |
NPD7824 |
Approved |
0.7204 |
Intermediate Similarity |
NPD6277 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD6476 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD6158 |
Phase 2 |
0.7192 |
Intermediate Similarity |
NPD8488 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD4880 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD6178 |
Phase 3 |
0.7177 |
Intermediate Similarity |
NPD7271 |
Approved |
0.7173 |
Intermediate Similarity |
NPD4499 |
Approved |
0.7171 |
Intermediate Similarity |
NPD8406 |
Clinical (unspecified phase) |
0.7168 |
Intermediate Similarity |
NPD1683 |
Approved |
0.7166 |
Intermediate Similarity |
NPD8408 |
Discontinued |
0.7158 |
Intermediate Similarity |
NPD3116 |
Approved |
0.7158 |
Intermediate Similarity |
NPD3117 |
Approved |
0.7152 |
Intermediate Similarity |
NPD3475 |
Approved |
0.7152 |
Intermediate Similarity |
NPD3476 |
Approved |
0.7151 |
Intermediate Similarity |
NPD8036 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD8037 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD5862 |
Discovery |
0.7128 |
Intermediate Similarity |
NPD5106 |
Approved |
0.7128 |
Intermediate Similarity |
NPD5105 |
Approved |
0.7128 |
Intermediate Similarity |
NPD5596 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD3385 |
Approved |
0.7122 |
Intermediate Similarity |
NPD6803 |
Clinical (unspecified phase) |
0.7111 |
Intermediate Similarity |
NPD8026 |
Phase 1 |
0.7109 |
Intermediate Similarity |
NPD7731 |
Approved |
0.7109 |
Intermediate Similarity |
NPD7730 |
Approved |
0.7107 |
Intermediate Similarity |
NPD484 |
Approved |
0.7107 |
Intermediate Similarity |
NPD6479 |
Discontinued |
0.7104 |
Intermediate Similarity |
NPD7474 |
Suspended |
0.7103 |
Intermediate Similarity |
NPD7558 |
Phase 2 |
0.7102 |
Intermediate Similarity |
NPD2882 |
Phase 1 |
0.7095 |
Intermediate Similarity |
NPD5255 |
Approved |
0.7087 |
Intermediate Similarity |
NPD7823 |
Clinical (unspecified phase) |
0.7079 |
Intermediate Similarity |
NPD2748 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD2118 |
Approved |
0.7073 |
Intermediate Similarity |
NPD2119 |
Approved |
0.7073 |
Intermediate Similarity |
NPD7707 |
Approved |
0.7072 |
Intermediate Similarity |
NPD5140 |
Approved |
0.7072 |
Intermediate Similarity |
NPD5138 |
Approved |
0.7071 |
Intermediate Similarity |
NPD7903 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD8629 |
Discontinued |
0.7068 |
Intermediate Similarity |
NPD6141 |
Clinical (unspecified phase) |
0.7065 |
Intermediate Similarity |
NPD8322 |
Phase 2 |
0.7065 |
Intermediate Similarity |
NPD1392 |
Approved |
0.7059 |
Intermediate Similarity |
NPD3330 |
Phase 1 |
0.705 |
Intermediate Similarity |
NPD6987 |
Phase 1 |
0.7047 |
Intermediate Similarity |
NPD6180 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD2509 |
Approved |
0.703 |
Intermediate Similarity |
NPD2510 |
Approved |
0.7029 |
Intermediate Similarity |
NPD1661 |
Suspended |
0.7027 |
Intermediate Similarity |
NPD7418 |
Discontinued |
0.7024 |
Intermediate Similarity |
NPD4029 |
Approved |
0.7024 |
Intermediate Similarity |
NPD4030 |
Approved |
0.7024
|
Intermediate Similarity |
NPD4028 |
Approved |